Pfizer mRNA Influenza Vaccine ‘Failed’ In Clinical Trial Among Seniors: FDA Commissioner
2nd December 2025
Pfizer’s experimental influenza vaccine will not receive approval absent new data proving that it protects seniors against the flu, the commissioner of the Food and Drug Administration suggested in a new interview.